BioStock: Respiratorius’ CEO: “Strong belief but patience regarding agreement”

Lund-based Respiratorius continues talks to reach an agreement regarding the drug candidate VAL001. The discussions are now focused on already established contacts, the company states in its newly released Q3 report. When BioStock contacted CEO Johan Drott to get his view of the past quarter, he was hopeful of reaching an agreement.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/respiratorius-ceo-strong-belief-but-patience-regarding-agreement/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se